About Ophthotech

Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases.

Ophthotech is leveraging its clinical experience and retina expertise to identify and develop therapies to treat multiple orphan ophthalmic diseases for which there are limited or no treatment options available.

In parallel, the Company is continuing its ongoing age-related retinal programs. The Company, through its business development efforts, is also pursuing opportunities to in-license or acquire rights to additional products, product candidates and technologies to treat ophthalmic diseases, particularly those of the back of the eye.